Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.
about
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1betaDay-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational studyMorphine induced allodynia in a child with brain tumour.Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study.Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study.Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor.Opioids in chronic non-cancer pain.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.The clinical heterogeneity of drug-induced myoclonus: an illustrated review.Renal function and symptoms/adverse effects in opioid-treated patients with cancer.Opioid-induced myoclonus and hyperalgesia following a short course of low-dose oral morphine.Myoclonus associated with concomitant ciprofloxacin and oxycodone in an older patient.Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine.Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
P2860
Q24656645-606B638C-CBFC-46F6-83E1-D5E536522C79Q24791044-B33EB600-D1D5-464B-AB2F-827A873EC7BBQ28343557-EA68EF64-1B6F-43FF-BB61-B5CEAE4096EDQ35752995-4DEAAB37-62F6-432A-8AC1-DB9288C10B92Q35823710-21E75085-0DAD-43A2-89BF-7D30AA8D457DQ35827481-6C99B82B-6768-4E98-9856-8D627F42A670Q36274644-92BE2C5C-E523-49C5-97E4-E4A20808844FQ37831309-12E79B90-91CB-47C5-AA16-E6B323A4A563Q37895002-0CB36937-0495-433B-A0C5-816BEDF8C558Q38255420-DB754295-B924-40C3-8387-EC900C875DC8Q38542687-8A6A2BB0-7DA4-45E0-9BEC-75C43165703DQ39040815-68BAA5E1-161A-41C6-B9F6-53F6047FFCE8Q41760447-089BA2C2-A052-41D1-965C-FAB8F161EADFQ42293483-7C1D6E0D-DE52-4FD3-8696-E8137DB41546Q42545820-83FEF852-D900-4FFF-B2D2-E606976B8B52Q43968416-2AF68B2D-BBB0-407B-8C85-1B71C223B9ACQ44862502-A18B7B8F-0CF9-4975-8B7F-AB99547F2C3CQ48672918-0A57EB1B-E428-4A5D-AC2E-3625BB051C33
P2860
Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Is development of hyperalgesia ...... istration? Six case histories.
@en
Is development of hyperalgesia ...... istration? Six case histories.
@nl
type
label
Is development of hyperalgesia ...... istration? Six case histories.
@en
Is development of hyperalgesia ...... istration? Six case histories.
@nl
prefLabel
Is development of hyperalgesia ...... istration? Six case histories.
@en
Is development of hyperalgesia ...... istration? Six case histories.
@nl
P2093
P2860
P1476
Is development of hyperalgesia ...... istration? Six case histories.
@en
P2093
L Christrup
L P Thunedborg
S H Hansen
P2860
P304
P356
10.1111/J.1399-6576.1998.TB05378.X
P407
P577
1998-10-01T00:00:00Z